Asian Journal of Advances in Medical Science

Cancer is the one of the deadly menace diseases with high medical significance which remains one of the keys that causes ailments and death, the security and firmness of the typical chemotherapeutics drugs and artificial agents used to accomplish cancer are doubtful now a days. These mediators affect the quality of life or sometimes they causative for progress of drug resistance and are not judicious to the majority of the patients So the clinical management of the cancer with high efficiency can done with the probiotic microbiota. An imbalance in the gut microbiota promotes the progress of carcinogenesis through several mechanisms, including inflammation, initiation of carcinogens, and tumorigenic pathways as well. In vivo and molecular studies have exhibited the support to role of probiotics in cancer. Probiotic agents are live microbes or components of microbes that have a positive effect on the host. They exert their action through interaction with the immune system of the host. Some of this effect is localized and some is in improvement in total body system. The Probiotic bacteria are the live microorganisms that, when directed in acceptable amounts, deliberate a healthy benefit on the host, and they have been considered for their protective anti-tumour effects. This review emphases on the role of probiotic microbiota as substitute for the prevention and treatment of cancer in the relation between gut microbiota and the progress of cancer.